Skip to main content

Table 2 Fatty acid composition of total serum lipids from patients with polymyositis and dermatomyositis before and after immunosuppressive treatment

From: Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis

FA Before treatment, weight % After treatment,weight %
C14:0 0.96 ± 0.48 1.33 ± 0.33
C16:0 22.78 ± 1.98 23.18 ± 1.60
C16:1 1.85 ± 0.84 2.06 ± 0.93
C18:0 10.76 ± 1.44 9.96 ± 1.33
C18:1 25.34 ± 3.53 24.02 ± 2.92
C18:2(n-6) 21.98 ± 3.34 23.02 ± 3.11
C18:3(n-6) 0.04 ± 0.12 0.17 ± 0.20
C18:3(n-3) 1.81 ± 1.03 2.37 ± 0.65
C20:1 0.3 ± 0.32 0.13 ± 0.26
C20:2(n-6) 0.1 ± 0.13 0.46 ± 0.37*
C20:3(n-6) 1.27 ± 0.36 1.31 ± 0.34
C20:4(n-6) 5.83 ± 1.61 4.96 ± 1.07
C20:5(n-3) 1.25 ± 0.44 1.91 ± 0.65*
C22:0 0.2 ± 0.45 0.2 ± 0.17
C22:5(n-3) 1.0 ± 0.44 1.18 ± 0.18
C22:6(n-3) 4.38 ± 1.77 3.55 ± 0.70
SFA 34.7 ± 2.6 34.9 ± 2.7
MUFA 26.4 ± 3.4 27.5 ± 4.5
PUFA 38.9 + 3.4 37.6 + 4.9
n-3 PUFA 9.0 ± 1.6 8.4 ± 1.9
n-6 PUFA 29.9 ± 2.8 29.2 ± 4.1
  1. Values given as mean ± SD
  2. FA fatty acids, SFA saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids
  3. *p < 0.05 for after treatment versus before treatment